Is it the end of the line for allergies thanks to the DBV-Technologies Viaskin patch?

Huge strides are being made in the field of epicutaneous immunotherapy. Click here if you’d like to discover more about the Paris firm that’s leading the charge.

Increasing numbers of individuals suffer from one or more allergy. Well-known allergies include foods such as egg, milk and peanuts.

DBV Technologies has been at the forefront of new research in the field in the shape of the Viaskin platform.

The Viaskin patch is a simple adhesive patch worn on the skin. The principal components of the patch revolve around its metal backing (PET titanium), breathable over-adhesive and adhesive crown.

The theory underlying the Viaskin patch might surprise you by its simplicity. Tiny amounts of the relevant allergen are sprayed upon the patch in an even coating, which then dries.Unlike in an injection, the antigens are solubilized and pass directly into the body’s most tolerogenic cells, the Langerhans cells, without entering the bloodstream. This gradually ‘tones down’ the body’s reaction to these antigens.

If you’re interested in finding out more about DBV-Technologies’ food allergy treatment techniques, see this page.